BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Latest Pharma Insights



Sorry, there are no news articles that match your search.

Coronavirus Update: AZ Gets $1bn From US, Secures Capacity For One Billion Vaccine Doses
Inovio vaccine data published, US government invests to protect, generic remdesivir launched in Bangladesh.  
Scrip - May 21, 2020
Post-IPO Zentalis Plows New Ground With China Oncology Venture
US venture raises new funds from Asia partners as it builds a direct presence in China to develop its oncology...
Scrip - May 21, 2020
India Pharma Webinar: COVID-19 Impact, Dealing With Business Continuity
Informa Markets’ recent webinar on COVID-19 and its impact on the Indian pharmaceutical industry deliberated a range of burning issues...
Scrip - May 21, 2020

WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry
An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be...
Pink Sheet - May 21, 2020
COVID-19: Global Agencies Step Up Focus On Real-World Data
There is much talk around the importance of clinical trials in finding new treatments and vaccines for COVID-19 patients, but...
Pink Sheet - May 21, 2020
Medicare's CAR-T Payment Change Helps the Entire Regenerative Medicine Field ... A Little Bit
Alliance for Regenerative Medicine says CMS' plan to create new reimbursement category for CAR-T helps validate entire field, but it may...
Pink Sheet - May 21, 2020
China-US Virus Showdown Creating Health Policy Uncertainties
China has stepped up its support for the World Health Organization just as the US is ratcheting up its criticism...
Pink Sheet - May 21, 2020
Small Biotech Companies Could Get Faster USPTO Review Of COVID-19 Patent Applications
Pilot program aims to examine applications for COVID-19 products subject to approval by FDA within 6 to 12 months; the...
Pink Sheet - May 21, 2020

Execs On The Move, May 2020
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
In Vivo - May 20, 2020
What Next For Medtech And Investors Post-Coronavirus?
If a post-COVID-19 economic recovery starts properly in September, as some have suggested, how swift would a return to normal...
In Vivo - May 20, 2020
Titans Of Pharma 2020: 15 Leading CEOs Bag $266m In Compensation
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies...
In Vivo - May 20, 2020

WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry
An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be...
Medtech Insight - May 21, 2020
Commission Invites European Standards Bodies To Accept MDR/IVDR Standardization Request
The European Commission has at last officially requested that CEN and CENELEC develop and update urgently needed standards to support...
Medtech Insight - May 21, 2020
QUOTED. 21 May 2020. Australia Therapeutic Goods Administration.
Australia’s regulatory agency said that over 40 test kits for COVID-19 are approved for inclusion in the Australian Register of...
Medtech Insight - May 21, 2020

Taisho Boosted By Acquisitions As Japanese Business Struggles
Acquiring France's UPSA helped to lift Taisho's sales in the 12 months ended 31 March 2020, as its domestic Japanese...
HBW Insight - May 21, 2020
David Vs Goliath – Flarin’s Macmillen On Slugging It Out With The Heavyweights
HBW Insight Exclusive: Flarin boss Andrew Macmillen on competing with the big OTC incumbents as a lean, innovation-focused company.
HBW Insight - May 21, 2020
J&J To End Johnson’s Baby Powder Sales In North American Markets, But Maintains Safety Convictions
The iconic talc-based product will no longer be available for purchase in the US and Canada after supplies run out...
HBW Insight - May 21, 2020
Back to the top Back to the top